Clinical Trials: EU Law

Department for Exiting the European Union written question – answered on 12th December 2017.

Alert me about debates like this

Photo of Chris Green Chris Green Conservative, Bolton West

To ask the Secretary of State for Exiting the European Union, what discussions he has had with the science and research community on ensuring that the UK will have compatible regulations with the EU clinical trials regulations after the UK leaves the EU.

Photo of Robin Walker Robin Walker The Parliamentary Under-Secretary of State for Exiting the European Union

The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the UK remains one of the best places in the world for science and innovation. As part of those negotiations the Government will discuss with the EU and Member States how best to continue cooperation in the field of clinical trials.

Stakeholder engagement is a central element of our plan to build a national consensus around our negotiating position; we are listening and talking to as many organisations, companies and institutions as possible. We have been working closely with business through the joint government and industry, UK EU Life Sciences Steering Group, to help identify the priorities for our future relationship with the EU for the benefit of patient health, including clinical trials. We have also engaged stakeholders from other sectors, including the Association of Medical Research Charities, to discuss cross cutting issues which may impact our future relationship on clinical trials. I also attend the Minister of State for Business, Energy and Industrial Strategy’s Stakeholder Working Group on EU Exit, Universities, Research and Innovation.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.